EichorEICHOR
Location: Concord Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Concord

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Concord Hospital · Ichnos Sciences SA · NCT05862012Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Atrium Health Cabarrus/LCI-Concord · NRG Oncology · NCT05624996Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · Concord Hospital · Monash University · NCT05678621Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213Molecular Genetics Studies of Cancer Patients and Their Relatives
Phase N/A · John Muir Medical Center-Concord Campus · City of Hope Medical Center · NCT04185935Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · Concord Repatriation General Hospital · PYC Therapeutics · NCT06714006Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Phase 2/Phase 3 · Mario Negri Institute for Pharmacological Research · NCT06126315EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Centricity Research (Vaughan) · Boehringer Ingelheim · NCT06531824Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Atrium Health Cabarrus/LCI-Concord · NRG Oncology · NCT06532279A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Concord Hospital · Biogen · NCT06962800A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
NA · Emerson Hospital/MGH Cancer Center · Massachusetts General Hospital · NCT06172907Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Phase 4 · Atrium Health Cabarrus · Wake Forest University Health Sciences · NCT05421741A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Concord Repatriation General Hospital · Boehringer Ingelheim · NCT07220083Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · New Hampshire Oncology Hematology PA-Concord · NRG Oncology · NCT05174169Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327IKS014 in Advanced Solid Tumors That Express HER2
Phase 1 · Concord Repatriation General Hospital Medical Oncology Clini · Iksuda Therapeutics Ltd. · NCT05872295ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · New Hampshire Oncology Hematology PA-Concord · Alliance for Clinical Trials in Oncology · NCT06876714Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
NA · Dartmouth Hitchcock Concord Family Medicine · Dartmouth-Hitchcock Medical Center · NCT06898593Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Atrium Health Cabarrus/LCI-Concord · Canadian Cancer Trials Group · NCT06592924A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · John Muir Medical Center /ID# 257103 · AbbVie · NCT06345339Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · Home-based telemedicine · Ensoma · NCT06605378E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Atrium Health Cabarrus/LCI-Concord · NRG Oncology · NCT06748222Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · NRG Oncology · NCT03180268Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Subo
NA · Concord Repatriation General Hospital · Concord Repatriation General Hospital · NCT04455932Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Phase 4 · Concord Repatriation and General Hospital · Todd C. Lee MD MPH FIDSA · NCT06637332Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · John Muir Medical Center-Concord · National Cancer Institute (NCI) · NCT05256225A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure
Phase 2 · Concord Repatriation General Hospital - Cardiology Departmen · Novo Nordisk A/S · NCT06979375A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site US10020 · Astellas Pharma Global Development, Inc. · NCT02960022
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.